Pyxis Oncology Inc (PYXS)
3.62
-0.10
(-2.69%)
USD |
NASDAQ |
Sep 27, 16:00
3.615
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Cash from Operations (Quarterly): -3.007M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.007M |
| March 31, 2024 | -20.71M |
| December 31, 2023 | -15.25M |
| September 30, 2023 | -17.58M |
| June 30, 2023 | -11.03M |
| March 31, 2023 | -26.84M |
| December 31, 2022 | -17.39M |
| Date | Value |
|---|---|
| September 30, 2022 | -20.56M |
| June 30, 2022 | -23.71M |
| March 31, 2022 | -27.68M |
| December 31, 2021 | -12.17M |
| September 30, 2021 | -7.288M |
| June 30, 2021 | 2.862M |
| March 31, 2021 | -18.73M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.68M
Minimum
Mar 2022
2.862M
Maximum
Jun 2021
-15.65M
Average
-17.48M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.004M |
| Cash from Financing (Quarterly) | 0.11M |
| Free Cash Flow | -56.85M |
| Free Cash Flow Per Share (Quarterly) | -0.0497 |
| Free Cash Flow Yield | -31.79% |